OVARIAN CANCER PANEL Test
Test Cost: AED 750.0
Test Name: OVARIAN CANCER PANEL Test
Components:
- CA 125
- Inhibin B
Price: 750.0 AED
Sample Condition:
4 mL (2 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery:
Sample Mon by 9 am; Report Same day
Method:
CMIA, EIA
Test Type:
Cancer
Doctor:
Oncologist
Test Department:
Pre Test Information:
No special preparation required
Test Details:
The Ovarian Cancer Panel test is a diagnostic test used to detect and diagnose ovarian cancer. It is a blood test that measures the levels of certain proteins and biomarkers that are associated with ovarian cancer. The test typically includes the measurement of several biomarkers, including CA-125, HE4, and other tumor markers. These biomarkers are often elevated in women with ovarian cancer, and their levels can help determine the presence and progression of the disease.
The Ovarian Cancer Panel test is commonly used in conjunction with other diagnostic tests, such as imaging studies and biopsies, to provide a comprehensive evaluation of ovarian cancer. It can help in the early detection and monitoring of the disease, as well as in determining the most appropriate treatment options.
It is important to note that while the Ovarian Cancer Panel test can be helpful in diagnosing ovarian cancer, it is not a definitive diagnostic tool. Further testing and evaluation by a healthcare professional are necessary to confirm a diagnosis and develop an appropriate treatment plan.
Test Name | OVARIAN CANCER PANEL Test |
---|---|
Components | *CA 125 *Inhibin B |
Price | 750.0 AED |
Sample Condition | 4 mL ( 2 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
Report Delivery | Sample Mon by 9 am; Report Same day |
Method | CMIA, EIA |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details | The Ovarian Cancer Panel test is a diagnostic test used to detect and diagnose ovarian cancer. It is a blood test that measures the levels of certain proteins and biomarkers that are associated with ovarian cancer. The test typically includes the measurement of several biomarkers, including CA-125, HE4, and other tumor markers. These biomarkers are often elevated in women with ovarian cancer, and their levels can help determine the presence and progression of the disease. The Ovarian Cancer Panel test is commonly used in conjunction with other diagnostic tests, such as imaging studies and biopsies, to provide a comprehensive evaluation of ovarian cancer. It can help in the early detection and monitoring of the disease, as well as in determining the most appropriate treatment options. It is important to note that while the Ovarian Cancer Panel test can be helpful in diagnosing ovarian cancer, it is not a definitive diagnostic tool. Further testing and evaluation by a healthcare professional are necessary to confirm a diagnosis and develop an appropriate treatment plan. |